Ultrasound-guided needle knife release of the transverse carpal ligament for carpal tunnel syndrome: a prospective case series study Authors: Qiao-Yin Zhou, Dan-Tong Wu, Jing-Yuan Zeng, Xiang-Yi You, Yun-Nan Li, Rong-Shui Dai, Ai-Hua Zhang Published: 2026 ABSTRACT BackgroundCarpal tunnel syndrome (CTS) is the most common entrapment neuropathy of the upper limb and seriously affects patients’ quality of life. Ultrasound-guided percutaneous release has emerged as a minimally invasive alternative to conventional surgery. This prospective case series aimed to evaluate the clinical efficacy and safety of ultrasound-guided needle knife release of the transverse carpal ligament in patients with CTS.MethodsEighteen patients diagnosed with CTS were enrolled and treated with ultrasound-guided needle knife release of the transverse carpal ligament. Clinical and electrophysiological assessments were performed at baseline and 3 days post-treatment, including sensory nerve conduction velocity (SNCV), distal motor latency (DML), compound muscle action potential (CMAP) amplitude, ultrasound imaging parameters, and Numerical Rating Scale (NRS) scores for pain and numbness. Telephone follow-ups were conducted at 1 and 3 months to evaluate NRS, Boston Carpal Tunnel Questionnaire (BCTQ), and Short-Form 36 (SF-36) scores.ResultsAt 3 days post-treatment, significant improvements were observed in the median nerve flattening ratio and NRS scores for both pain and numbness (P<0.05). At 1 and 3 months, significant improvements were maintained in pain intensity, numbness intensity, symptom severity, and functional status as measured by BCTQ. The SF-36 domains of physical functioning (PF), bodily pain (BP), general health (GH), vitality (VT), role emotional (RE), and mental health (MH) all showed significant improvements at both time points, while social functioning (SF) showed significant improvement at 3 months (P<0.05). No adverse events were observed during the study period.ConclusionsIn this preliminary prospective case series, ultrasound-guided needle knife release of the transverse carpal ligament was associated with significant improvements in symptoms, hand function, and quality of life in patients with CTS, with a favorable safety profile. These findings support its potential as a minimally invasive treatment option for CTS. Introduction Carpal tunnel syndrome (CTS) is the most common neuropathy in the upper limbs (1), and its main symptoms include sensory disorders, manifested as abnormal sensation, numbness, or stinging in the fingers. As the condition progresses, motor symptoms may be observed, which may lead to atrophy of the thenar or other muscles innervated by the median nerve (2). A severe condition can have a negative impact on a patient’s quality of life. According to the diagnostic criteria, the incidence of CTS is approximately 7% to 14.4% (3,4). A recent study reported that in the United States alone, 1 to 3 cases of CTS per 1,000 people are documented per year (5). Even according to records, the incidence rate of CTS can reach 150 cases per 1,000 people every year (6). In addition, CTS is more common in people over 40 years old and may be related to physical activity. Other underlying conditions can also increase the risk of CTS, such as rheumatism and endocrine disorders; inflammatory changes; skeletal, muscular, and neurovascular abnormalities; tumor lesions; and pregnancy (4,7). At present, the treatment for CTS includes methods such as splint fixation, steroid injection, traditional needle knife treatment, and surgical treatment, each with its own advantages and disadvantages (8-10). In recent years, with the popularization of ultrasound visualization technology, minimally invasive ultrasound-guided needle knife technology has also achieved good therapeutic effects on various types of nerve compression and soft tissue diseases (11-14). In a preliminary study, we designed a fixation technique for ultrasound-guided needle knife release of the transverse carpal ligament using 52 fixed cadaver upper limb specimens and confirmed the accuracy and safety of this technique (15). Although previous studies have documented quality of life outcomes in CTS patients following various treatments, limited data exist regarding systematic evaluation of symptom and quality of life changes specifically after ultrasound-guided needle knife release. This study aims to provide preliminary findings in this context (16). Currently, a preliminary case series study is being conducted on CTS patients using electrophysiological examinations, ultrasound imaging, a numerical rating scale (NRS), the Boston Carpal Tunnel Questionnaire (BCTQ), and a 36-item short-form health survey questionnaire (SF-36) to explore the clinical efficacy of ultrasound-guided needle knife release of the transverse carpal ligament in the treatment of CTS. We present this article in accordance with the TREND reporting checklist (available at https://qims.amegroups.com/article/view/10.21037/qims-2026-0553/rc). Methods Recruitment of research subjects From January 1, 2021, to December 31, 2022, recruitment was conducted by placing recruitment posters and public accounts in the outpatient Department of Acupuncture and Moxibustion Department of The Third People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine. Trained researchers screened subjects strictly according to the diagnosis, inclusion criteria and exclusion criteria. This study was conducted in accordance with the Declaration of Helsinki and its subsequent amendments. The study was approved by the Ethics Committee of The Third People’s Hospital Affiliated to Fujian University of Traditional Chinese Medicine (No. 2021ks-7-1), and informed consent forms were signed by the patients or family members. Diagnosis and inclusion criteria (I) The inclusion criteria were based on the diagnostic characteristics of carpal tunnel syndrome in the “Clinical Diagnosis and Treatment Guide · Physical Medicine and Rehabilitation”, (i) intermittent or persistent pain and numbness in the three and a half fingers of the palm radialis, some radiating to the upper limb, aggravated in the morning or at night; (ii) no major thenar muscle atrophy, thumb or palm dysfunction or other severe symptoms; (iii) a decrease or disappearance of the sensation of the thumb, index finger, middle finger, or radial palmar surface of the ring finger, and a positive Tinel sign and Phalen sign; and (iv) an electrophysiological diagnosis of incomplete median nerve injury or an ultrasound diagnosis of CTS. (II) The subjects who signed the informed consent letter had good compliance with the observations and evaluations of the researchers. Exclusion criteria (I) Severe CTS, such as great thenar muscle atrophy and thumb-palm dysfunction; (II) carpal tunnel stenosis caused by fracture or other space-occupying lesions; (III) severe diabetes mellitus and cardiovascular and cerebrovascular diseases; (IV) abnormal coagulation function; (V) thyroid gland functional abnormalities, gout and other immune diseases; (VI) pregnant women; and (VII) unable to adhere to the completion of the research program. Treatment method No local or general anesthesia was administered during the procedure. Ultrasound-guided needle knife was used for localization in previous studies (15). The patient lay supine, and the affected wrist was placed flat on the diagnosis and treatment bed, with the wrist pad elevated, the palm upward, and the five fingers naturally straightened. After touching the palmar longus tendon with the hand, the ulnar edge of the palmar longus tendon was opened 3 mm to the ulnar side and intersected the proximal wrist transverse line at point A. Point B was located at the junction of the middle finger and the ring finger, and line AB was connected. According to the initial description of the Kaplan line, the vertex of the interphalangeal fold between the thumb and the index finger was drawn to the ulnar side of the hand, parallel to the middle crease of the hand (17), and this line was drawn. After palpating the hook bone and the trapezium bone by hand, the high-frequency ultrasound probe of the Acclarix ultrasound instrument was placed on the line connecting the two, and the distal boundary of the transverse carpal ligament was identified by transverse scanning for precise localization. The midline of the transverse axis of the ultrasound probe always overlapped with line AB. After marking the surface depth and the bottom depth of the transverse carpal ligament in the ultrasound image, the probe was rotated 90° for longitudinal scanning, and the midline of the longitudinal axis of the ultrasound probe always overlapped with line AB. Then, the needle was inserted into the plane at the distal end of the transverse carpal ligament approximately 3 mm from the probe, which was needle insertion point 1 (Figure 1). Needle insertion point 1 did not exceed the Kaplan line. The proximal-to-distal approach was adopted based on our previous cadaveric study (15). This approach allows better visualization of the median nerve and reduces iatrogenic injury. During needle insertion, the angle between the needle body of the needle knife and the skin was approximately 20°, and the knife surface was vertical to the skin. The ultrasound image showed that the needle knife (length: 65 mm, diameter: 1.0 mm) (Figure 2A) reached the surface of the transverse carpal ligament through the skin, and then the needle was pushed and released. The needle tip was maintained at a vertical position no deeper than the pre‑marked deep margin of the transverse carpal ligament on ultrasound. During the pushing process, the feeling of tough tissue being cut under the needle knife could be obviously felt. The needle was pushed 5 times until the tissue was loose (Figure 2B). Schematic diagram of the insertion of the needle and surrounding anatomical structures for ultrasound-guided needle knife release of the transverse carpal ligament. 1, proximal transverse carpal striae; 2, superficial transverse palmar ligament; 3, palmar longus tendon; 4, transverse carpal ligament; 5, median nerve; 6, ulnar artery; 7, ulnar nerve; 8, Kaplan line; 9, palmar superficial arch; A: the intersection of the palmar longus tendon with 3 mm lateral to the ulnar side and the transverse stripes of the proximal wrist; B: the intersection of the ring finger and the middle finger. Reproduced from (15). This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY). Schematic diagram and ultrasound images of ultrasound-guided needle-knife release. (A) Needle knife. (B) Long axis view of ultrasound-guided needle knife release of the transverse carpal ligament. Triangle marking needle knife. *, median nerve. Cap, capitate bone; FDS, flexor digitorum superficialis; Met, metacarpal bone; TCL, transverse carpal ligament. The insertion technique for point 2 was similar to that for point 1. After touching the scaphoid and pisiform bone by hand, the high-frequency ultrasound probe was placed on the line connecting the two. Transverse scanning identified the proximal boundary of the transverse carpal ligament for precise positioning. The midline of the transverse axis of the ultrasound probe always overlapped with line AB. After the surface depth and bottom depth of the transverse carpal ligament were marked in the ultrasound image, the probe was turned for longitudinal scanning. The midline of the longitudinal axis of the ultrasound probe always overlapped with line AB. Then, the needle was inserted in the plane at the proximal end of the transverse carpal ligament approximately 3 mm away from the probe, which was needle insertion point 2 (Figure 1). When the needle was inserted, the angle of the needle knife to the skin was approximately 20°, and the knife surface was vertical to the skin. When the ultrasound image showed that the needle knife penetrated the skin and reached the surface of the transverse carpal ligament, pushing release was performed. The needle tip should be kept no deeper than the pre‑marked deep margin of the transverse carpal ligament on ultrasound. During the pushing process, the feeling of tough tissue being cut under the needle knife could be obviously felt. The needle was removed after 5 pushes until the tissue had a sense of loosening. After release, compression was applied for 5 min to stop bleeding, and the wound was bandaged with sterile gauze. All patients were treated by one physician. No rehabilitation exercises, physical therapy, or additional medication was prescribed as part of the study protocol. Observation indicators Electrophysiological examinations of the patient's median nerve sensory nerve conduction velocity (SNCV), median nerve distal motor latency (DML), and compound muscle action potential (CMAP) amplitude were performed. Electrophysiological examinations of the patient's median nerve sensory nerve conduction velocity (SNCV), median nerve distal motor latency (DML), and compound muscle action potential (CMAP) amplitude were performed. Ultrasound imaging detected the flattening rate (FR) of the proximal median nerve in the carpal tunnel (flattening rate = transverse diameter/anterior-posterior diameter) and the thickness of the transverse carpal ligament (TCL); stress elastography observed changes in tissue hardness within the carpal tunnel. Ultrasound imaging detected the flattening rate (FR) of the proximal median nerve in the carpal tunnel (flattening rate = transverse diameter/anterior-posterior diameter) and the thickness of the transverse carpal ligament (TCL); stress elastography observed changes in tissue hardness within the carpal tunnel. The NRS score was used to assess the degree of pain and numbness. The NRS score was used to assess the degree of pain and numbness. The BCTQ assessed functional status and symptom severity. Scores for the symptom severity scale and functional status scale were calculated separately. The BCTQ assessed functional status and symptom severity. Scores for the symptom severity scale and functional status scale were calculated separately. The SF-36 assessed the patient's quality of life. The scores for the following 8 subscales were calculated: physical functioning (PF), role physical (RP), body pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH). The calculation formula for each subscale is as follows: score = (actual score − lowest possible score in the aspect)/(highest possible score in the aspect − lowest possible score) × 100%. The SF-36 assessed the patient's quality of life. The scores for the following 8 subscales were calculated: physical functioning (PF), role physical (RP), body pain (BP), general health (GH), vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH). The calculation formula for each subscale is as follows: score = (actual score − lowest possible score in the aspect)/(highest possible score in the aspect − lowest possible score) × 100%. Tests (I)–(V)were conducted, and the scale was completed before treatment. Three days after treatment, items (I)–(III) were checked, and the scale was completed. After 1 month and 3 months of treatment, telephone follow-up was conducted to complete items (III)–(V) of the scale. Statistical analysis The smallest unit of analysis was the individual participant. All statistical analyses were performed using SPSS version 27.0. Data were presented as median with interquartile range (IQR, i.e., 25th–75th percentiles). For comparisons between two time points (e.g., pretreatment vs. posttreatment), the Wilcoxon signedrank test was used. For comparisons involving three or more time points, the Friedman test was first applied to assess overall differences, followed by posthoc pairwise comparisons using the Wilcoxon signedrank test with Bonferroni correction for multiple comparisons. A twotailed P value <0.05 was considered statistically significant. For multiple comparisons, the adjusted significance level was set according to the Bonferroni method (e.g., α =0.05/number of comparisons). Results General information This study included 18 patients who met the inclusion criteria (Table 1). Table 1General informationVariablePatient (n=18), nSex (male/female)3/15Location (left/right/double)8/6/4 General information The patients included 3 males, accounting for 16.67%, and 15 females, accounting for 83.33%, with a male to female ratio of 1:5. The longest course of illness was 80 months, and the shortest was 4 months. The disease course was mostly between 24–48 months and 48–96 months, with 5 patients each, accounting for 27.78% of the patients (Figure 3). The course of disease of 18 cases. Electrophysiological examination Electrophysiological examination was completed in 8 of the 18 patients (44.4%), because the remaining 10 patients did not complete the follow-up electrophysiological examination due to geographic distance, scheduling conflicts, or refusal to participate. The results revealed no statistically significant differences (P>0.05) in the amplitudes of the SNCV, DML, or CMAP waves between 3 days after treatment and before treatment (Table 2). Table 2Changes in electrophysiological examination data between 3 days after treatment and pretreatmentGroupNPretreatment, median (IQR)3d, median (IQR)PSNCV (m/s)827.00 (22.43, 29.95)31.85 (27.05, 36.80)0.078DML (ms)85.85 (4.42, 6.49)4.34 (3.22, 6.53)0.109CMAP (μV)84.80 (2.65, 21.63)8.55 (7.50, 27.30)0.383Electrophysiological data available for 8 patients (n=8). 3d, 3 days after treatment; CMAP, compound muscle action potential; DML, distal motor latency; IQR, interquartile range; SNCV, sensory nerve conduction velocity. Changes in electrophysiological examination data between 3 days after treatment and pretreatment Electrophysiological data available for 8 patients (n=8). 3d, 3 days after treatment; CMAP, compound muscle action potential; DML, distal motor latency; IQR, interquartile range; SNCV, sensory nerve conduction velocity. Ultrasound imaging Ultrasound imaging was completed in 8 of the 18 patients (44.4%), because the remaining 10 patients did not complete the ultrasound imaging due to geographic distance, scheduling conflicts, or refusal to participate. On ultrasound, the median nerve flatness ratio changed significantly (P<0.05) between baseline and 3 days after treatment. Regarding TCL thickness, the median value decreased from 2.25 to 1.65 mm, but this change was not statistically significant (P>0.05) (Table 3). Table 3Results of indexes before and after treatment were comparedGroupNPretreatment, median (IQR)3d, median (IQR)PTCL thickness (mm)82.25 (2.13, 2.70)1.65 (1.60, 2.00)0.086Median nerve flatness rate83.64 (3.36, 4.37)3.02 (2.81, 3.11)0.008Ultrasound imaging data available for 8 patients (n=8). 3d, 3 days after treatment; IQR, interquartile range; TCL, transverse carpal ligament. Results of indexes before and after treatment were compared Ultrasound imaging data available for 8 patients (n=8). 3d, 3 days after treatment; IQR, interquartile range; TCL, transverse carpal ligament. Both the short-axis and long-axis ultrasound images showed the recovery of the nerve diameter after ultrasound-guided needle knife release, and stress elastography showed that the median nerve tissue changed from hard to soft (Figures 4-6). Ultrasound short-axis view of proximal carpal tunnel before and after treatment. FDS, flexor digitorum superficialis; Lun, lunate bone; N, median nerve; Pis, pisiform bone; R, radial; Sca, scaphoid bone; TCL, transverse carpal ligament; Tri, triquetral bone; U, ulnar. Ultrasonic long axis view of carpal tunnel before and after treatment. The arrows mark the nerve compression site. *, median nerve. Cap, capitate bone; FDS, flexor digitorum superficialis; Met, metacarpal bone; TCL, transverse carpal ligament. Short-axis ultrasound stress elastography of proximal carpal tunnel before and after treatment. FDS, flexor digitorum superficialis; Lun, lunate bone; N, median nerve; Pis, pisiform bone; R, radial; Sca, scaphoid bone; TCL, transverse carpal ligament; U, ulnar. Comparison of NRS scores before and after treatment Significant differences in the pain and numbness intensity scores were observed before and after treatment (P<0.0125). There were no significant differences among the 3 days, 1 month, and 3 months post‑treatment assessments (P>0.0125), and the scores showed a decreasing trend over time (Table 4). Table 4Results of numbness intensity score before and after treatmentGroupNPretreatment, median (IQR)3d, median (IQR)1m, median (IQR)3m, median (IQR)P3d vs. 1m3d vs. 3m1m vs. 3mPain186.00 (0.75, 8.00)2.00 (0.00, 3.25)*2.00 (0.00, 3.00)*1.00 (0.00, 2.25)*0.6350.5980.236Numbness186.50 (5.00, 8.00)3.00 (0.75, 4.25)*2.00 (1.00, 3.25)*1.00 (0.75, 4.00)*0.4140.1080.207P values for post-treatment pairwise comparisons were adjusted by Bonferroni method (α =0.0125). *, P<0.0125 versus pre-treatment (Bonferroni correction for 4 comparisons). 1m, 1 month after treatment; 3d, 3 days after treatment; 3m, 3 months after treatment; IQR, interquartile range. Results of numbness intensity score before and after treatment P values for post-treatment pairwise comparisons were adjusted by Bonferroni method (α =0.0125). *, P<0.0125 versus pre-treatment (Bonferroni correction for 4 comparisons). 1m, 1 month after treatment; 3d, 3 days after treatment; 3m, 3 months after treatment; IQR, interquartile range. Comparison of BCTQ scores before and after treatment For both the Stanford Sleepiness Scale (SSS) and Fatigue Severity Scale (FSS) scores, significant differences were observed between pretreatment and the 1‑ and 3‑month post‑treatment assessments (P<0.0167), whereas no significant differences were found between the 1‑ and 3‑month assessments (P>0.0167) (Table 5). Table 5Results of BCTQ before and after treatmentGroupNPretreatment, median (IQR)1m, median (IQR)3m, median (IQR)P (1m vs. 3m)SSS1831.00 (28.00, 36.00)18.00 (16.00, 21.25)*16.00 (14.00, 18.75)*0.597FSS1821.00 (14.25, 27.50)9.50 (9.00, 15.25)*9.00 (8.00, 12.25)*0.117P values for post-treatment pairwise comparisons were adjusted by Bonferroni method (α =0.0167). *, P<0.0167 versus pretreatment (Bonferroni correction for 4 comparisons). 1m, 1 month after treatment; 3m, 3 months after treatment; BCTQ, Boston Carpal Tunnel Questionnaire; FSS, Fatigue Severity Scale; IQR, interquartile range; SSS, Stanford Sleepiness Scale. Results of BCTQ before and after treatment P values for post-treatment pairwise comparisons were adjusted by Bonferroni method (α =0.0167). *, P<0.0167 versus pretreatment (Bonferroni correction for 4 comparisons). 1m, 1 month after treatment; 3m, 3 months after treatment; BCTQ, Boston Carpal Tunnel Questionnaire; FSS, Fatigue Severity Scale; IQR, interquartile range; SSS, Stanford Sleepiness Scale. Comparison of SF-36 scores before and after treatment Based on the questionnaire, for PF, BP, GH, VT, RE and MH, significant differences were observed between pretreatment and both the 1 month and 3 months posttreatment assessments (P<0.0167). For SF, a significant difference was found between pretreatment and the 3 months assessment (P<0.0167). Additionally, for BP and VT, significant differences were also noted between the 1 month and 3 months posttreatment assessments (P<0.0167). No other significant differences were found for any other comparisons between time points (P>0.0167) (Table 6). Table 6Results of health state investigation questionnaire before and after treatmentGroupNPretreatment, median (IQR)1m, median (IQR)3m, median (IQR)P (1m vs. 3m)PF180.70 (0.64, 0.76)0.90 (0.80, 0.95)*0.95 (0.80, 0.95)*0.564RP180.50 (0.00, 1.00)0.63 (0.25, 1.00)0.63 (0.00, 1.00)–BP180.47 (0.30, 0.74)0.80 (0.62, 0.90)*0.87 (0.74, 0.91)*0.008GH180.40 (0.24, 0.61)0.57 (0.47, 0.77)*0.64 (0.52, 0.78)*0.136VT180.60 (0.39, 0.75)0.70 (0.55, 0.80)*0.78 (0.55, 0.85)*0.011SF180.63 (0.47, 0.91)0.88 (0.72, 1.00)1.00 (0.84, 1.00)*0.063RE180.33 (0.00, 1.00)1.00 (0.67, 1.00)*1.00 (1.00, 1.00)*0.250MH180.72 (0.47, 0.80)0.80 (0.71, 0.92)*0.82 (0.71, 0.89)*0.828HTQ180.50 (0.25, 0.75)0.50 (0.50, 0.75)0.75 (0.50, 0.75)–P values for post-treatment pairwise comparisons were adjusted by Bonferroni method (α =0.0167). *, P<0.0167 versus pre-treatment (Bonferroni correction for 4 comparisons). 1m, 1 month after treatment; 3m, 3 months after treatment; BP, body pain; GH, general health; HTQ, Health Transition Question; IQR, interquartile range; MH, mental health; PF, physical functioning; RE, role emotional; RP, role physical; SF, social functioning; VT, vitality. Results of health state investigation questionnaire before and after treatment P values for post-treatment pairwise comparisons were adjusted by Bonferroni method (α =0.0167). *, P<0.0167 versus pre-treatment (Bonferroni correction for 4 comparisons). 1m, 1 month after treatment; 3m, 3 months after treatment; BP, body pain; GH, general health; HTQ, Health Transition Question; IQR, interquartile range; MH, mental health; PF, physical functioning; RE, role emotional; RP, role physical; SF, social functioning; VT, vitality. Adverse events No adverse events, including nerve injury, infection, hematoma, bleeding, or allergic reactions, were observed during or after the procedure in any of the 18 patients. Discussion The results of this study showed that ultrasound-guided needle knife release was associated with a significant reduction in the nerve flattening rate, while ultrasound stress elastography showed that the tissues within the carpal tunnel became significantly softer after treatment. In addition to an evaluation, minimally invasive ultrasound-guided needle knife technology has gradually become popular in clinical practice. Needle knife therapy is a closed surgery for cutting, stripping, and dredging the lesion site under nonvisual conditions. Due to blind nature, this procedure may lead to adverse events (18). Ultrasound guidance is the best method for enhancing the safety of the needle knife operation. The portability of existing ultrasound equipment and the clarity of imaging technology have been able to meet the needs of needle knife visualization diagnosis and treatment, and real-time guidance can be achieved during treatment to increase safety and accuracy (15,19,20). No iatrogenic injury was observed in these 18 CTS patients who underwent ultrasound-guided needle-knife release, suggesting the short-term feasibility of the procedure. Pain and numbness are the most common clinical symptoms in patients with carpal tunnel syndrome (21). When the median nerve is compressed, the blood circulation of the nerve is affected, resulting in ischemic edema and congestion and leading to a nutritional disturbance and subsequent nerve atrophy, which induces the development of carpal tunnel syndrome (22). Ultrasound-guided needle knife releases the transverse carpal ligament, reduces pressure in the carpal tunnel and relieves nerve compression, thus alleviating patients’ clinical symptoms. In this study, after ultrasound-guided needle knife release, A significant alleviation of numbness symptoms was observed at 3 days after surgery (P<0.05), and the pain symptoms also showed significant differences when comparing scores recorded before treatment and 3 months after treatment. In addition to numbness and pain symptoms, the recovery of the hand function status is also a key factor in evaluating the efficacy of treatment. Many questionnaires have been developed to assess upper limb diseases, but the Boston Carpal Tunnel Questionnaire is most commonly used as a disease-specific tool for assessing CTS (23). The BCTQ is a patient-based questionnaire with indicators of symptom severity and functional status outcomes that was specifically developed for patients with CTS. It has good acceptability, with a patient response rate of more than 90%, making it convenient for the follow-up of patients in clinical studies (24). Although the BCTQ is subjective, it is a self-administered questionnaire that eliminates bias and is sensitive to clinical changes (25). In addition, some scholars (26) suggest that the symptom severity subscale and functional status subscale of the BCTQ should be evaluated as two separate subscales rather than being summarized into a total score. In this study, the SSS and FSS scores showed a significant decrease at 1 and 3 months after treatment, indicating that ultrasound-guided needle knife release of the transverse carpal ligament can be associated with significant improvement in the clinical symptoms of patients with CTS and reduce the degree of hand dysfunction. Although no differences in the changes in the SNCV, DML, or CMAP amplitude s were observed after 3 days of treatment, the SNCV and CMAP amplitudes tended to increase, while the DML tended to decrease. This finding is also consistent with other literature reports (27), in which no differences were observed in the electrophysiological parameters of the median nerve, including the SNCV, DML, and CMAP, between pre- and postoperative measurements at 7 days and 1 month after surgery. A significant difference was observed compared to the preoperative measurements only at 3 months after surgery. This difference may be related to the slow repair of the compressed and damaged median nerve (28). Furthermore, the severity of the electrophysiological diagnosis of CTS may not be correlated with clinical severity (29). In this study, PF, BP, GH, VT and RE showed significant improvement at both one month and three months after ultrasound-guided needle knife release therapy, and SF showed significant improvement at three months after treatment, indicating that patients’ symptoms improved while their psychological emotions were also alleviated. Repetitive activities of extending and flexing the wrist, common in housewives and teachers, are also risk factors for the development of CTS (30). This suggests that patients should be advised to minimize repetitive wrist activities after treatment, and if symptoms do not improve or worsen, further surgery may be necessary (31). To clarify the clinical positioning of ultrasound-guided needle-knife release within the current treatment paradigm for CTS, we provide a brief comparative overview with other commonly used procedures. Compared with traditional open release, ultrasound-guided needle knife release avoids a large palmar incision, thereby reducing postoperative hypertrophic scarring and facilitating faster recovery (32). Relative to endoscopic release, it does not require specialized endoscopic equipment, is associated with shorter recovery time, causes less iatrogenic injury to the superficial structures of the wrist, and incurs lower costs (33). In contrast to ultrasound-guided hydrodissection—which primarily separates perineural adhesions via fluid pressure—ultrasound-guided needle knife release enables precise division of the transverse carpal ligament under real‑time sonography while sparing adjacent nerves, thus providing more definitive mechanical decompression; moreover, some studies have suggested that it may offer more durable long‑term outcomes (34). Currently, this technique is mainly indicated for patients with mild‑to‑moderate CTS who have failed conservative management, and represents a safe, effective, and cost‑effective minimally invasive option. This study has several limitations. It was a singlecenter prospective case series without a control group, so causal inferences cannot be drawn. The sample size was small (n=18) and no power analysis was performed, making the findings preliminary and hypothesisgenerating. In addition, a considerable proportion of patients did not complete the objective electrophysiological and ultrasound follow-up examinations, which introduces a risk of attrition bias and may limit the generalisability of the objective outcome findings. The followup period of three months is too short to assess longterm durability or late recurrence. In addition, follow‑up at one and three months was conducted by telephone and relied on patient‑reported outcome measures (NRS, BCTQ, SF‑36), which may introduce recall bias and lack objective verification of clinical status. Electrophysiological followup and ultrasound imaging was completed in only eight patients, and no testing was done at one or three months, which means objective nerve recovery data were missed. Although we applied Bonferroni correction for multiple comparisons to reduce the risk of type I error, the exploratory nature of this small sample study still warrants cautious interpretation of the findings. Ultrasound parameters were not systematically recorded, limiting reproducibility. We are addressing these limitations in future studies by expanding sample sizes, extending followup periods, conducting systematic electrophysiological assessments, and using internationally recognized outcome measures. Conclusions In this prospective case series of 18 patients with carpal tunnel syndrome, ultrasound-guided needle knife release of the transverse carpal ligament was associated with short-term improvements in pain, numbness, hand function, and quality of life, as well as reductions in median nerve flattening ratio and transverse carpal ligament thickness. However, given the absence of a control group, and the small sample size, these findings should be considered preliminary and hypothesis-generating. No causal conclusions can be drawn from this observational study. Future studies with more rigorous designs are needed to confirm these associations. Supplementary The article’s supplementary files as